In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosaKatherine Young, Mary Motyl, Timothy A. Blizzard et al.|BMC Microbiology|2019Cited by 126
Elucidation of DnaE as the Antibacterial Target of the Natural Product, NargenicinRonald E. Painter, Katherine Young, Gregory C. Adam et al.|Chemistry & Biology|2015Cited by 40
Linking High-Throughput Screens to Identify MoAs and Novel Inhibitors of <i>Mycobacterium tuberculosis</i> Dihydrofolate ReductaseJohn P. Santa Maria, Peter S. Kutchukian, Yumi Park et al.|ACS Chemical Biology|2017Cited by 28
Rapid Evolution of a Fragment-like Molecule to Pan-Metallo-Beta-Lactamase Inhibitors: Initial Leads toward Clinical CandidatesMihirbaran Mandal, Haifeng Tang, Li Xiao et al.|Journal of Medicinal Chemistry|2022Cited by 27
Affinity Selection–Mass Spectrometry Identifies a Novel Antibacterial RNA Polymerase InhibitorScott S. Walker, Katherine Young, Jing Su et al.|ACS Chemical Biology|2017Cited by 17